PMID: 16639080Apr 28, 2006Paper

BRCA1 downregulation leads to premature inactivation of spindle checkpoint and confers paclitaxel resistance

Cell Cycle
C ChabalierF Larminat

Abstract

BRCA1 germline mutations predispose women to early onset, familial breast and ovarian cancer. BRCA1 has been recently implicated in the cellular response to agents that disrupt the mitotic spindle. In this report, we studied BRCA1 contribution to paclitaxel response in MCF-7 breast cancer cells. We show that MCF-7 cells transfected with BRCA1 siRNA display a significant increase in resistance to paclitaxel compared with the control cells. We next demonstrate that downregulation of BRCA1 reduces the mitotic index and triggers premature cyclin B1 degradation and decrease in Cdk1 activity following paclitaxel treatment, suggesting that BRCA1 downregulation results in precocious inactivation of the spindle checkpoint. These findings were confirmed by showing that BRCA1 downregulation induces premature sister-chromatids separation in MCF-7 cells following spindle damage. Furthermore, we show that BRCA1 up-regulates the expression of the protein kinase BubR1, essential component of the functional spindle checkpoint, whose downregulation is known to result in paclitaxel resistance in MCF-7 cells. Altogether, our findings support the notion that downregulation of BRCA1 expression mediates paclitaxel resistance through premature inactiv...Continue Reading

Citations

Oct 24, 2008·International Journal of Clinical Oncology·Yasuo MiyoshiKoushi Oh
May 18, 2010·Wiener medizinische Wochenschrift·Rupert BartschGuenther G Steger
Jul 14, 2012·Breast Cancer Research and Treatment·Soley Bayraktar, Stefan Glück
May 2, 2009·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Junichi Kurebayashi
Oct 20, 2010·Nature Reviews. Clinical Oncology·Steven A Narod
Feb 15, 2012·Nature Reviews. Clinical Oncology·Sophie Postel-VinayJean-Charles Soria
Mar 1, 2012·Oncogene·S CatuognoV de Franciscis
Nov 11, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O GluzN Harbeck
Dec 9, 2008·The Cancer Journal·Antoinette R Tan, Sandra M Swain
Jan 26, 2011·The Cancer Journal·Rafael RosellJose Miguel Sanchez
Dec 14, 2011·The Cancer Journal·Karen Lisa Smith, Claudine Isaacs
Aug 9, 2011·Hereditary Cancer in Clinical Practice·Evgeny N Imyanitov, Vladimir M Moiseyenko
Nov 8, 2007·PloS One·Rafael RosellJacek Jassem
Nov 8, 2012·Breast Cancer : Basic and Clinical Research·W J Gradishar
Jan 25, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Tamar SafraFranco M Muggia
Aug 2, 2014·The Journal of Clinical Investigation·Eun Myoung ShinVinay Tergaonkar
Mar 18, 2011·Women's Health·Anastasia Pazaiti, Ian S Fentiman
Jun 7, 2011·Oncogene·S GiovinazziA M Ishov
May 22, 2010·Expert Opinion on Pharmacotherapy·Rafael RosellBartomeu Massuti
Nov 1, 2009·Expert Opinion on Medical Diagnostics·Jia WeiRafael Rosell
Feb 10, 2016·Frontiers in Surgery·Doreen M Agnese, Raphael E Pollock
May 13, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ana Belén CustodioEduardo Díaz-Rubio
Dec 3, 2014·Biotechnology Advances·Shengpeng WangMeiwan Chen
Sep 25, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S J DawsonC Caldas
Mar 19, 2009·Advanced Drug Delivery Reviews·Romano DanesiRafael Rosell
Jan 27, 2009·Gynecologic Oncology·Jennifer E QuinnD Paul Harkin
Jul 29, 2008·Critical Reviews in Oncology/hematology·Antonio RussoGaetana Di Fede
Dec 11, 2007·Biochimica Et Biophysica Acta·Barbara T McGroganAmanda McCann
Nov 28, 2008·International Journal of Cancer. Journal International Du Cancer·Johanne WeberpalsJim Dimitroulakos
Jan 4, 2008·Histopathology·J S Reis-Filho, A N J Tutt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.